谷歌浏览器插件
订阅小程序
在清言上使用

Clinical Outcomes of COVID-19 in Patients with Multiple Sclerosis Treated with Ocrelizumab in the Pre- and Post-Sars-cov-2 Vaccination Periods: Insights from Israel

Multiple sclerosis and related disorders(2022)

引用 1|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要